Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:1372:57-65.
doi: 10.1007/978-981-19-0394-6_5.

Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins

Affiliations

Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins

Jahangir Iqbal et al. Adv Exp Med Biol. 2022.

Abstract

Sphingolipids are biomolecules with diverse physiological functions in signaling as well as plasma membrane structure. They are associated with either cellular membranes or plasma lipoproteins and any changes in their levels may contribute to certain metabolic diseases. Sphingolipids are evenly distributed in lipoproteins and may be used as prognostic and diagnostic markers. Mechanisms involved in the transport of sphingolipids have been recently explored and here we discuss the most recent advances in the molecular mechanisms of sphingolipids transport by lipoproteins. It has been shown that microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter family A protein 1 (ABCA1) play an important role in plasma sphingolipid homeostasis. However, the exact mechanisms are not well known. Though much research has already been done to emphasize the impact of sphingolipids changes in many pathological disorders, understanding mechanisms by which circulating lipoproteins assist in transporting sphingolipids may provide novel information that may help in devising strategies to therapeutically target these pathways to treat various metabolic disorders.

Keywords: ABCA1; Abetalipoproteinemia; Ceramides; Hexosylceramides; Lipoproteins; MTP; Sphingolipids; Sphingomyelin; Sphingosine-1-phosphate; Tangier disease.

PubMed Disclaimer

Similar articles

References

    1. Borodzicz, S., Czarzasta, K., Kuch, M., & Cudnoch-Jedrzejewska, A. (2015). Sphingolipids in cardiovascular diseases and metabolic disorders. Lipids in Health and Disease, 14, 55. - PubMed - PMC - DOI
    1. Kitatani, K., Idkowiak-Baldys, J., & Hannun, Y. A. (2008). The sphingolipid salvage pathway in ceramide metabolism and signaling. Cellular Signalling, 20(6), 1010–1018. - PubMed - DOI
    1. D’Angelo, G., Uemura, T., Chuang, C. C., Polishchuk, E., Santoro, M., Ohvo-Rekila, H., et al. (2013). Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature, 501(7465), 116–120. - PubMed - DOI
    1. Wang, X., Rao, R. P., Kosakowska-Cholody, T., Masood, M. A., Southon, E., Zhang, H., et al. (2009). Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. The Journal of Cell Biology, 184(1), 143–158. - PubMed - PMC - DOI
    1. Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., et al. (2003). Molecular machinery for non-vesicular trafficking of ceramide. Nature, 426(6968), 803–809. - PubMed - DOI

LinkOut - more resources